MYC and hepatocellular carcinoma: Numerous studies have demonstrated the therapeutic efficacy of statins in HCC outside of clinical meta‐analysis.[31, 32] Inflammation, angiogenesis or MYC signal might be the targets of statins for cancer therapy.